Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.
March 26, 2014
AgeneBio Received US Patent
Agenebio Inc. was issued U.S. Patent No. 8,604,075, “Methods and compositions for improving cognitive function,” and No. 8,510,055, “Methods for characterizing and treating cognitive impairment in aging and disease.” Both cover the company’s programs for Alzheimer’s disease and other cognitive disorders.
